Evidence map›Paper›PMID 40979990›Full record

ArticleEuropean heart journal supplements : journal of the European Society of Cardiology2025

May Measurement Month 2022: an analysis of blood pressure screening results from Bangladesh.

Fazila-Tun-Nesa Malik, Mohammad Abdullah Al Mamun, Mir Ishraquzzaman, Md Kalimuddin, Mohammad Shamimur Rahman, Shamim Jubayer, Thomas Beaney, Gabriele Kerr, Mithila Faruque, Sohel Reza Choudhury and 1 more

Abstract read
In one paragraph

Article in European heart journal supplements : journal of the European Society of Cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Fazila-Tun-Nesa MalikDepartment of Epidemiology & Research, National Heart Foundation Hospital & Research Institute, Dhaka 1216, Bangladesh.
Mohammad Abdullah Al MamunDepartment of Epidemiology & Research, National Heart Foundation Hospital & Research Institute, Dhaka 1216, Bangladesh.
Mir IshraquzzamanDepartment of Epidemiology & Research, National Heart Foundation Hospital & Research Institute, Dhaka 1216, Bangladesh.
Md KalimuddinDepartment of Epidemiology & Research, National Heart Foundation Hospital & Research Institute, Dhaka 1216, Bangladesh.
Mohammad Shamimur RahmanDepartment of Epidemiology & Research, National Heart Foundation Hospital & Research Institute, Dhaka 1216, Bangladesh.
Shamim JubayerDepartment of Epidemiology & Research, National Heart Foundation Hospital & Research Institute, Dhaka 1216, Bangladesh.
Thomas BeaneyImperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.ORCID https://orcid.org/0000-0001-9709-7264
Gabriele KerrImperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Mithila FaruqueDepartment of Non-Communicable Diseases, Bangladesh University of Health Science, Dhaka, Bangladesh.
Sohel Reza ChoudhuryDepartment of Epidemiology & Research, National Heart Foundation Hospital & Research Institute, Dhaka 1216, Bangladesh.
Neil R PoulterImperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Bangladesh, about one in four adults aged 18-69 years are hypertensive. Nationwide periodic blood pressure (BP) screening campaigns are helpful in identifying undiagnosed patients. The May Measurement Month (MMM) campaign was carried out in Bangladesh in 2022 with the aim of raising awareness of raised BP. Here, we report on the findings of the campaign. Adults aged ≥18 years were recruited opportunistically at 100 screening sites in 27 districts in Bangladesh. Three seated BP readings were taken for each participant, along with the completion of a questionnaire on demographics, lifestyle factors, and comorbidities. Hypertension was defined as a systolic BP ≥ 140 mmHg and/or diastolic BP ≥ 90 mmHg or being on antihypertensive medication. Controlled BP was defined as being on antihypertensive medication with a BP <140/90 mmHg. Multiple imputation was used to estimate any missing BP readings. In total, 16 544 were screened, with a mean age of 47.4 years and 51.7% of whom were female. Of all participants, 9654 (58.4%) had hypertension, of whom 8593 (89.0%) were aware, and 8087 (83.8%) were on antihypertensive medication. Of those on antihypertensive medication, 4014 (49.6%) had controlled BP, and of all participants with hypertension, 41.6% had controlled BP. The MMM campaign in Bangladesh identified significant numbers of participants with either untreated or inadequately treated hypertension. Ensuring effective detection and treatment of raised BP is one of the most cost-effective ways to prevent death and disability due to high BP.

Indexed as

Blood pressureControlHypertensionScreeningTreatment

Identifiers

PMID40979990
PMCPMC12449173

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.